Medical device licence · 86325 · Class 2
QUANTIA A1-ANTITRYPSIN
Yes: licensed in Canada
Licence status Issued (active); first licensed June 13, 2011. It is in Health Canada’s list of active licences.
- Licence number
- 86325
- Licence holder
- Biokit S.A.Lliçà D'Amunt, 08, Spain
- Risk class
- Class II (low to moderate risk)
- Licence type
- Test Kit
- First licensed
- June 13, 2011
- Devices covered
- 1
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- QUANTIA A1-ANTITRYPSIN
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.